Suppr超能文献

荧光光谱和多模态荧光成像如何帮助剖析万古霉素-利福平联合用药对抗金黄色葡萄球菌感染的增效作用?

How do fluorescence spectroscopy and multimodal fluorescence imaging help to dissect the enhanced efficiency of the vancomycin-rifampin combination against Staphylococcus aureus infections?

机构信息

Institut des Sciences Moléculaires d'Orsay (ISMO), CNRS, Univ. Paris-Sud, Université Paris-Saclay, F-91405 Orsay, France.

出版信息

Photochem Photobiol Sci. 2017 Sep 13;16(9):1391-1399. doi: 10.1039/c7pp00079k.

Abstract

Staphylococcus aureus is one of the most frequent pathogens responsible for biofilm-associated infections. Among current clinical antibiotics, very few enable long-term successful treatment. Thus, it becomes necessary to better understand antibiotic failures and successes in treating infections in order to master the use of proper antibiotic therapies. In this context, we took benefit from a set of fluorescence spectroscopy and imaging methods, with the support of conventional microbiological tools to better understand the vancomycin-rifampin combination (in)efficiency against S. aureus biofilms. It was shown that both antibiotics interacted by forming a complex. This latter allowed a faster penetration of the drugs before dissociating from each other to interact with their respective biological targets. However, sufficiently high concentrations of free vancomycin should be maintained, either by increasing the vancomycin concentration or by applying repetitive doses of the two drugs, in order to eradicate rifampin-resistant mutants.

摘要

金黄色葡萄球菌是引起生物膜相关感染的最常见病原体之一。在目前的临床抗生素中,很少有能够长期成功治疗的抗生素。因此,有必要更好地了解抗生素治疗感染的失败和成功,以便掌握适当抗生素治疗的使用。在这种情况下,我们利用了一系列荧光光谱和成像方法,并辅以常规微生物学工具,以更好地了解万古霉素和利福平联合(不)对抗金黄色葡萄球菌生物膜的效果。结果表明,两种抗生素通过形成复合物相互作用。该复合物允许药物更快地穿透,然后再相互分离以与各自的生物靶标相互作用。然而,为了根除利福平耐药突变体,应该保持足够高的游离万古霉素浓度,要么通过增加万古霉素浓度,要么通过重复使用两种药物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验